Newron Pharmaceuticals S.p.A. (FRA:NP5)
9.86
+0.83 (9.19%)
At close: Sep 5, 2025
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of €198.80 million as of September 10, 2025. Its market cap has increased by 27.38% in one year.
Market Cap
198.80M
Enterprise Value
239.68M
Revenue
51.39M
Ranking
n/a
PE Ratio
12.55
Stock Price
€9.86
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 194.15M to 198.80M, an increase of 2.39%. That is a compound annual growth rate of 0.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 9, 2025 | 198.80M | 7.43% |
Dec 30, 2024 | 185.06M | 94.99% |
Dec 29, 2023 | 94.91M | 239.07% |
Dec 30, 2022 | 27.99M | 0.21% |
Dec 30, 2021 | 27.93M | -20.96% |
Dec 30, 2020 | 35.34M | -66.13% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 265.82B |
Siemens Aktiengesellschaft | 175.47B |
Deutsche Telekom AG | 153.80B |
Allianz SE | 133.88B |
Rheinmetall AG | 79.93B |
Siemens Energy AG | 69.21B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.78B |
Deutsche Bank Aktiengesellschaft | 57.25B |